Infectious disease and the need for more options
By learning from the past, we may have a much better arsenal against antimicrobial-resistant bacteria in the near future.
Greg Merril
Greg Merrill is founder and CEO of Adaptive Phage Therapeutics, a clinical-stage company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria.